You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
In this publication a comprehensive overview of the state of the art and future perspectives is given in the fields of basic research, diagnosis, therapy, suicide and relapse prevention, and psychiatric care regarding patients with affective disorders. Presented are decisive new developments which have been milestones in basic research or diagnosis, pharmacotherapy and psychotherapy of affective disorders. The contributions of renowned experts in the field include quantitative brain morphology and developments in genetics and neurochemistry. Special attention has been given to neuropharmacology, pharmacogenetics, electrophysiology, structural and functional neuroimaging of affective disorders as well as new therapeutic options in the field of psychotherapy. Moreover, important clinical issues such as modern aspects of preventing relapse, suicide and postnatal depression in mothers are discussed. Psychiatrists, psychotherapists, neurobiologists and students who participate in the treatment of patients with affective diseases will find this book valuable reading.
This publication offers cutting-edge information about basic neurochemical and neuroimmunological research as well as clinical studies of immunological disarrangements and immunological dysfunctions in psychiatric disorders. Psychiatrists and immunologists in the clinic, and researchers in basic sciences will also find this book essential reading. Likewise, it will be relevant to graduate and undergraduate students with a special interest in the neurobiology of psychiatric disorders.'
In addition, fundamental questions concerning the bi-directional interactions between the central nervous system and the immune system are discussed and the role of viruses and infectious processes closely examined. As such, this book offers a unique presentation of the state of the art in psychoimmunology and, at the same time, shows many important challenges for future research into the field of intersystemic interactions and their impact on the etiology and pathogenesis of psychiatric diseases.
This book tries to close the gap between immunological findings on the one hand, psychological, psychopathological, electrophysiological and neuroimaging aspetcs on the other. It deals with the issue of "cause and effect” (of immunological alternatives) in different organic and/or mental disorders, and emphasizes the necessity of considering a variety of treatment strategies. There are dynamic interactions and several important similarities between the immune system and the central nervous system, which help to lay the rational basis for "psychoimmunology”. Both systems have the capacity for memory and both play vital roles in adaptation and defence. Furthermore, in each system pathological changes can occur in the event of inappropriate responses to internal or external stimuli, leading to psychiatric as well as organic illnesses and autoimmune diseases could also arise as a consequence of dysfunction respectively maladaptation. "... this book is a good way to approach the field of psychoimmunology, and shows that scientists are very active in this domain ...” Acta Neurologica Belgica.
In recent years, there have been major developments in the fields of pharmacogenetics and pharmacogenomics, with the potential to make drug treatments in psychiatric medicine more effective. However, improvements in drug efficacy and tolerability, as well as finding the optimal dosage, can only be realized if in vivo mechanisms of drug action and ADME (absorption, distribution, metabolism, excretion) processes (pharmacokinetics) of psychopharmacological agents are better understood. In this volume, current progress and perspectives in pharmacogenetic testing of drug-metabolizing enzymes, drug transporters and other drug targets involved in the response to psychotropic agents are described extensively. This provides a timely overview of what has been achieved in the area of psychiatric pharmacogenomics alongside some promising directions and perspectives for future research. Psychiatrists, general medical doctors as well as pharmacologists and clinical pharmacologists will find new insights into the development and applications of pharmacogenomics in psychiatry.
None
Suicide is one of the most important causes of death in modern societies. To develop more effective preventive measures, we have to be aware of and learn more about its neurobiological foundations. In recent years, the tools of modern neurosciences have increasingly been utilized to characterize the pathophysiology of complex human behaviors such as suicide. To improve suicide risk assessment and suicide prevention, a better understanding of its pathophysiology is crucial. This includes research from a variety of disciplines such as neuropsychological, psychosocial and cultural studies but also findings from biochemistry, neuropathology, electrophysiology, immunology, neuroimaging, genetics,...
Das Buch behandelt die jüngste Entwicklung der Schizophrenieforschung. Vor dem theoretischen Hintergrund des Vulnerabilitätsmodells wird ein Brückenschlag zwischen biologischen und psychosozialen Ansätzen vorgeschlagen, der nicht zuletzt für die Behandlung schizophrener Menschen in Zukunft differenziertere Therapieansätze verspricht. Im ersten Teil werden nach einer allgemeinen Übersicht über biologische Forschungsansätze auf dem Gebiet der Schizophrenien zunächst aktuelle neuropathologische Befunde referiert. Darüber hinaus werden moderne Möglichkeiten im Bereich der bildgebenden Verfahren dargestellt. Der 2. Teil des Buches enthält neuere empirische Untersuchungen zur Bedeutung der Familienpathologie für die Ätiologie und den Verlauf schizophrener Erkrankungen. Das Buch vermittelt dem interessierten Leser einen klar gegliederten, übersichtlichen Überblick über den neuesten Stand der neurobiologischen Schizophrenieforschung.
Since the publication of Neurobiology of Cerebrospinal Fluid 1 in 1980, that text has become the definitive reference concerning cerebrospinal fluid (CSF) for both basic scientists and clinicians involved in the investigation of degenerative, convulsive, cerebrovascular, traumatic, immunological, demyelinating, inflammatory, neoplastic, neuroendocrine, and psychiatric disorders. That initial volume began a tradition of detailed topic reviews written by international authorities with first-hand expertise in their respective fields of CSF research. Neurobiology of Cerebrospinal Fluid 2 represents a hefty collection of extensively refer enced and illustrated chapters covering topics not discuss...